Bridges over troubled water: Incubators and start-ups’ alliances

Bridges over troubled waters: education and cognitive neuroscience.

Recently there has been growing interest in and debate about the relation between cognitive neuroscience and education. Our goal is to advance the debate beyond both recitation of potentially education-related cognitive neuroscience findings and the claim that a bridge between fields is chimerical. In an attempt to begin a dialogue about mechanisms among students, educators, researchers and pra...

Revenue and Knowledge Cooperation Mechanisms between Business Incubators and Venture Capitalists for Collaborative Start-Ups

Business incubators and venture capital are effective instruments for supporting the development of new firms. The purpose of this paper is to explore cooperation mechanisms between business incubators and venture capitalists and find the equilibriums of the mechanisms. Also, this paper puts forward three mechanisms, revenue sharing mechanism, cost sharing mechanism and knowledge sharing mechan...

Health economics. A bridge over troubled water.

In a recent issue of the European Journal of Public Health Barendregt and Bonneux 1 argue that 'the trouble with health economies', in particular economic evaluations of health care programmes, is that outcomes 'depend to a large extent on arbitrary decisions in study design', while in more theoretical discussions economists would 'display an unseemly rigidness'. Barendregt and Bonneux conclude...

Building and Managing Strategic Alliances in Technology-Driven Start-Ups: A Critical Review of Literature

Low molecular weight heparin: a bridge over troubled water.

adjunct to fibrinolysis (with streptokinase only) validate continued interest in pursuing better thrombin inhibitors. Low molecular weight, active site thrombin inhibitors, (argatroban and melogatran) are currently approved (for HIT) or are in late stage clinical trials. In addition, new parenteral agents which block the coagulation cascade upstream of thrombin, by targeting Factor VII/tissue f...